Published in Lupus on May 01, 2009
Diffuse Calcifications of the Spleen in a Woman with Systemic Lupus Erythematosus. Case Rep Med (2015) 0.75
A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med (1999) 6.08
Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med (1997) 2.67
European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis (2001) 2.49
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis (2010) 2.38
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum (2012) 1.96
Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum (2001) 1.93
AKT1(E17K) in human solid tumours. Oncogene (2008) 1.87
Type 1 fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: evidence of subclinical myogenic myopathy. J Am Coll Cardiol (1989) 1.76
Absence of response to early transcranial magnetic stimulation in ischemic stroke patients: prognostic value for hand motor recovery. Stroke (1999) 1.73
Cerebral oxygenation during warming after cardiopulmonary bypass. Crit Care Med (1997) 1.63
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. Rheumatology (Oxford) (2002) 1.61
p53 inhibits alpha 6 beta 4 integrin survival signaling by promoting the caspase 3-dependent cleavage of AKT/PKB. J Cell Biol (1999) 1.46
Quality control for biomarker determination in oncology: the experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT). Int J Biol Markers (2002) 1.40
Granulocytopenia after combined therapy with interferon and angiotensin-converting enzyme inhibitors: evidence for a synergistic hematologic toxicity. Am J Med (1995) 1.40
Cooperative signaling between alpha(6)beta(4) integrin and ErbB-2 receptor is required to promote phosphatidylinositol 3-kinase-dependent invasion. J Biol Chem (2000) 1.40
Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res (1997) 1.39
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum (2005) 1.37
Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol Pharmacol (2002) 1.31
Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases. Ann Rheum Dis (2007) 1.27
Endothelial heme oxygenase-1 induction by hypoxia. Modulation by inducible nitric-oxide synthase and S-nitrosothiols. J Biol Chem (2000) 1.25
p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study. Br J Cancer (1997) 1.21
Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries. J Virol (2001) 1.19
Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA). Clin Exp Immunol (2000) 1.18
Interference with p53 protein inhibits hematopoietic and muscle differentiation. J Cell Biol (1996) 1.15
The chromosome location of the human homolog of the mouse mammary tumor-associated gene INT6 and its status in human breast carcinomas. Genomics (1997) 1.15
Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up. Clin Cancer Res (1996) 1.14
Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. Clin Rheumatol (1998) 1.13
EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells. Ann Rheum Dis (2008) 1.13
Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas. Br J Cancer (1996) 1.12
Recommended guidelines for uniform reporting of data from drowning: the "Utstein style". Resuscitation (2003) 1.09
Hormesis: its impact on medicine and health. Hum Exp Toxicol (2012) 1.08
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres. Ann Rheum Dis (2011) 1.05
Recommended guidelines for uniform reporting of data from drowning: the "Utstein style". Circulation (2003) 1.05
p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival. Br J Cancer (1996) 1.04
Collagen loss and impaired wound healing is associated with c-Myb deficiency. J Pathol (2007) 1.04
European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Ann Rheum Dis (2001) 1.04
Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. Clin Exp Immunol (1994) 1.02
Cyclin-D1-gene amplification and expression in breast carcinoma: relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21WAF1 immunohistochemical expression. Int J Cancer (1997) 1.02
Spatio-temporal anomalous diffusion in heterogeneous media by nuclear magnetic resonance. J Chem Phys (2011) 1.02
Juvenile rheumatoid arthritis patients manifest immune reactivity to the mycobacterial 65-kDa heat shock protein, to its 180-188 peptide, and to a partially homologous peptide of the proteoglycan link protein. Clin Immunol Immunopathol (1992) 0.98
Redox proteomics in aging rat brain: involvement of mitochondrial reduced glutathione status and mitochondrial protein oxidation in the aging process. J Neurosci Res (2010) 0.98
Detection of p53 mutations by single-strand conformation polymorphisms (SSCP) gel electrophoresis. A comparative study of radioactive and nonradioactive silver-stained SSCP analysis. Diagn Mol Pathol (1995) 0.98
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". Autoimmun Rev (2005) 0.97
Activation of p53 function in carcinoma cells by the alpha6beta4 integrin. J Biol Chem (1999) 0.97
Assessment of gastrointestinal involvement. Clin Exp Rheumatol (2003) 0.96
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol (2010) 0.96
In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress. Neuroscience (2006) 0.95
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors. Ann Oncol (2012) 0.95
Duration of effect of botulinum toxin type A in adult patients with cervical dystonia: a retrospective chart review. Clin Ther (2000) 0.95
Bullous SLE: response to methotrexate and relationship with disease activity. Lupus (2003) 0.95
Human monoclonal recombinant Fabs specific for HCV antigens obtained by repertoire cloning in phage display combinatorial vectors. Res Virol (1997) 0.94
The effects of Italian Mediterranean organic diet (IMOD) on health status. Curr Pharm Des (2010) 0.94
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. Dig Liver Dis (2007) 0.93
K-ras and p16(INK4A)alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers. Lung Cancer (2004) 0.93
Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon. Clin Immunol Immunopathol (1993) 0.92
Body composition and -174G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome. Curr Pharm Des (2008) 0.92
Self-stabilized fractality of seacoasts through damped erosion. Phys Rev Lett (2004) 0.92
The respiratory system during resuscitation: a review of the history, risk of infection during assisted ventilation, respiratory mechanics, and ventilation strategies for patients with an unprotected airway. Resuscitation (2001) 0.92
Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy. Ann Oncol (1996) 0.91
Implementing gnathological and neuromuscular concepts in patients with chronic migraine. Neurol Sci (2012) 0.91
Antibodies to mycobacterial 65 kDa heat shock protein in systemic sclerosis (scleroderma). J Autoimmun (1992) 0.90
Monocytes of patients wiht systemic sclerosis (scleroderma spontaneously release in vitro increased amounts of superoxide anion. J Invest Dermatol (1999) 0.90
Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder. Br J Rheumatol (1997) 0.90
Presence of hepatitis C virus (HCV) genomic RNA and viral replicative intermediates in bone marrow and peripheral blood mononuclear cells from HCV-infected patients. Clin Diagn Lab Immunol (1994) 0.89
A modified retrosigmoid approach for direct exposure of the fundus of the internal auditory canal for hearing preservation in acoustic neuroma surgery. Am J Otol (2000) 0.89
Diagnostic and therapeutic ERCP in patients with Billroth II gastrectomy. Acta Gastroenterol Belg (1994) 0.88
Preliminary classification criteria for the cryoglobulinaemic vasculitis. Ann Rheum Dis (2011) 0.88
A novel transducer for the measurement of cement-prosthesis interface forces in cemented orthopaedic devices. Med Eng Phys (2000) 0.88
Oxidatively-modified and glycated proteins as candidate pro-inflammatory toxins in uremia and dialysis patients. Amino Acids (2007) 0.88
Anisotropic anomalous diffusion assessed in the human brain by scalar invariant indices. Magn Reson Med (2010) 0.88
p53 is involved in the differentiation but not in the differentiation-associated apoptosis of myoblasts. Cell Death Differ (2000) 0.87
Evolution of Pseudomonas aeruginosa virulence in infected patients revealed in a Dictyostelium discoideum host model. Clin Microbiol Infect (2011) 0.87
Prevalence of asthma and rhinitis in Perugia, Italy. Monaldi Arch Chest Dis (1997) 0.87
Antibodies against galactosyl (alpha 1----3) galactose in connective tissue diseases. Arthritis Rheum (1991) 0.86
An epistatic mini-circuitry between the transcription factors Snail and HNF4α controls liver stem cell and hepatocyte features exhorting opposite regulation on stemness-inhibiting microRNAs. Cell Death Differ (2011) 0.86
Hearing preservation surgery in acoustic neuroma: long-term results. Acta Otorhinolaryngol Ital (2012) 0.86
Exogenous wt-p53 protein is active in transformed cells but not in their non-transformed counterparts: implications for cancer gene therapy without tumor targeting. J Gene Med (2000) 0.86
Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study. J Rheumatol (2001) 0.86
AIRE gene polymorphisms in systemic sclerosis associated with autoimmune thyroiditis. Clin Immunol (2006) 0.86
The chromosomal location of the mouse mammary tumor gene Int6 and related pseudogenes in the mouse genome. Genomics (1995) 0.86
Absence of somatic mutations in the coding region of the waf1/cip1 gene in human breast, lung and ovarian carcinomas - a polymorphism at codon-31. Int J Oncol (1995) 0.85
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study. Lupus (2003) 0.85
Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection? J Hepatol (1998) 0.85
Risk factors for Sjögren's syndrome: a case-control study. Clin Exp Rheumatol (2007) 0.85
Cooperative transformation of 32D cells by the combined expression of IRS-1 and V-Ha-Ras. Oncogene (2000) 0.85
Near infrared spectroscopy and multivariate analysis methods for monitoring flour performance in an industrial bread-making process. Anal Chim Acta (2009) 0.85
Anti-topoisomerase II alpha autoantibodies in systemic sclerosis-association with pulmonary hypertension and HLA-B35. Clin Exp Immunol (2000) 0.84
Scleroderma fibroblasts constitutively express the long pentraxin PTX3. Clin Exp Rheumatol (2004) 0.84
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies. J Biol Regul Homeost Agents (2003) 0.84
Residual and recurrent acoustic neuroma in hearing preservation procedures: neuroradiologic and surgical findings. Skull Base Surg (1996) 0.84
Thornell's approach for arytenoidectomy in the surgical treatment of bilateral abductor paralysis; personal experience and results. J Laryngol Otol (1985) 0.84
Nuclear DNA strand breaks during ethanol-induced oxidative stress in rat brain. FEBS Lett (1996) 0.84
Positive outcome of occlusal freeway space reestablishment in patients with medication overuse due to chronic migraine. Neurol Sci (2013) 0.83
Prevalence of isolated left ventricular diastolic dysfunction in hypertension as assessed by combined transmitral and pulmonary vein flow Doppler study. Am J Cardiol (2001) 0.83
Ultrastructural features of the intestinal absorption of mouse mammary tumor virus in newborn BALB/cfRIII mice. Gastroenterology (1989) 0.83
Redox regulation of cellular stress response in multiple sclerosis. Biochem Pharmacol (2011) 0.83
Association tests with systemic lupus erythematosus (SLE) of IL10 markers indicate a direct involvement of a CA repeat in the 5' regulatory region. Genes Immun (2002) 0.83
Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells. Br J Cancer (2001) 0.83
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes. Rheumatology (Oxford) (2005) 0.83